Introduction
Maintenance of a warm, regulated core body temperature (Tb) is a defining feature of mammals and birds. In homeotherms, hypothermia can be caused by excessive cold exposure, severe injury or illness, and many drugs. In large mammals, such as adult humans, hypothermia is relatively difficult to achieve. In contrast, small mammals, such as mice, are at risk of hypothermia and expend relatively massive amounts of energy to maintain their Tb, a process in which brown fat has a large role. The high energetic cost of defending Tb means that small mammals have evolved strategies for using Tb reduction to conserve fuel. For example, with cold exposure or fasting, mice let their Tb fall slightly (~1 C). Mice can also enter torpor, during which Tb can fall >10 C, producing huge energetic savings (Gavrilova et al., 1999; Geiser, 2004; Hudson and Scott, 1979; Melvin and Andrews, 2009) .
Hypothermia is observed with severe injury (Shafi et al., 2005 ) and sepsis (Fonseca et al., 2016) . It is unknown if the poor prognosis associated with hypothermia is because hypothermia is a marker of clinical severity or if the hypothermia represents a physiologic response to the dire situation (Fonseca et al., 2016) . Clinically, therapeutic hypothermia is used after insults such as neonatal hypoxic injury (Azzopardi et al., 2014) and cardiac arrest (Callaway et al., 2015) , and prophylactically during certain types of hypoperfusion surgery (Yan et al., 2013) . Therapeutic hypothermia is induced by cooling, sometimes with pharmacologic agents to block shivering. Drugs that induce hypothermia through reduction of the central Tb balance point could minimize counter-regulatory mechanisms such as shivering and provide clinical benefit.
Extracellular adenosine is one of the body's danger signals, an indicator of tissue damage or metabolic stress (Borea et al., 2016) . Adenosine acts at four G protein-coupled receptors: A 1 AR, A 2A AR, A 2B AR, and A 3 AR. A 1 AR and A 3 AR are typically coupled to Gi, while A 2A AR and A 2B AR are usually coupled to Gs or Gq. Adenosine has many actions that dampen immune and inflammatory responses, one of which is causing hypothermia (Bennet and Drury, 1931) . The best studied mechanism of adenosine-induced hypothermia is via agonism of brain A 1 AR, with proposed sites of action being the anterior hypothalamus and the nucleus of the solitary tract (Anderson et al., 1994; Carlin et al., 2017; Johansson et al., 2001; Muzzi et al., 2013; Shintani et al., 2005; Tupone et al., 2013) . However, mouse genetic and pharmacologic evidence suggested that adenosine can cause hypothermia via other mechanisms (Yang et al., 2007 (Yang et al., , 2010 . Hypothermia via A 3 AR is caused by agonism of peripheral mast cell A 3 AR, causing histamine release, which produces hypothermia via central histamine H 1 receptors (Carlin et al., 2016) . Since A 1 AR agonists must penetrate the brain to produce hypothermia, some compounds used as A 1 AR agonists may be causing hypothermia via peripheral mast cell A 3 AR (Carlin et al., 2017) .
There is limited information on the role of A 2A AR and A 2B AR in hypothermia. The A 2A AR agonist CGS-21680 produced mild hypothermia with a high i.c.v. dose (Anderson et al., 1994) or with peripheral dosing (Eisner et al., 2017) . These effects were smaller than those seen with agonism at other adenosine receptors and were not investigated mechanistically. Intraarterial CGS-21680 caused hypotension in wild type but not Adora2a À/À mice, which may have been accompanied by hypothermia, but Tb was not measured (Ledent et al., 1997) . In contrast, the A 2A AR agonist PSB-0777 increased energy expenditure by stimulation of brown adipose tissue; effects on Tb were not reported (Gnad et al., 2014) . No role for A 2B AR in hypothermia has been identified (Fredholm et al., 2011) .
Here we explored whether agonism at A 1 AR and A 3 AR completely accounts for the hypothermia potential of adenosine, or if A 2A AR and A 2B AR can also contribute. We find that agonism of either A 2A AR or A 2B AR does cause hypothermia, and investigate the pharmacology and mechanisms.
Materials and methods

Mice
Male C57BL/6 J and Kit WÀsh/WÀsh (JAX #012861) (Grimbaldeston et al., 2005; Nigrovic et al., 2008) mice were obtained from the Jackson Laboratory. Adora1 À/À (Sun et al., 2001 ), Adora3 Salvatore et al., 2000) , and Adora1
À/À
;Adora3 À/À mice were obtained and genotyped as reported (Carlin et al., 2017) . Adora2a
mice (Chen et al., 1999 ) on a mixed background were obtained from Dr. Dorian McGavern and genotyped as described (JAX #010685). Adora2b À/À mice (Hua et al., 2007) on a C57BL/6 J background were obtained from Dr. Stephen Tilley and genotyped as described (JAX #022499). Mice were singly housed at~22 C with a 12:12-h lightdark cycle (lights on at 6:00 a.m. and total physical activity (10e60 min). Data are mean ± SEM, n ¼ 5e6/group in a crossover design; ***p < 0.001 vs vehicle within genotype.
Adenosine receptor binding affinities
Binding affinity for mouse A 1 AR, A 2A AR, and A 3 ARs was measured as described (Kreckler et al., 2006) 
Thermal physiology phenotyping
Implantation (coordinates relative to bregma: À0.34 mm anterior, 1.0 mm lateral, and þ1.7 mm ventral) and use of chronic intracerebroventricular cannulas are described in (Carlin et al., 2017) , as are the following procedures. Continuous telemetric monitoring of Tb and activity were performed using G2 Emitters (Starr Life Sciences, Oakmont, PA) implanted intraperitoneally. Average Tb response was calculated using 0e60 min from agonist dosing and activity from 10 to 60 min. Inhibitors were dosed 20e25 min before agonists. Indirect calorimetry was performed using a 12-chamber CLAMS (Columbus Instruments, Columbus, OH).
Drug-induced neuronal activation
Sixty min after i.c.v. infusion, mice were euthanized with 7% chloral hydrate and perfused with saline followed by 4% paraformaldehyde in phosphate buffered saline (PBS, pH 7.4). Brains were post fixed in 4% paraformaldehyde/30% sucrose in PBS at 4 C overnight. Coronal brain sections (40 mm) were cut, stored at 4 C for up to one week in PBS containing 0.02% sodium azide, washed in 0.1 M PBS, preincubated in blocking buffer (PBS þ 0.2% triton X-100 þ 10% normal horse serum (NHS)) for 2 h at room temperature, and incubated with antibody to Fos (1:2000, Cell Signaling, #5348) in 2% NHS blocking buffer for 48 h at 4 C. After washing in PBS, tissue was incubated for 4 h with donkey anti-rabbit Alexa Fluor 488 antibody (1:500 in PBS þ 2% NHS blocking buffer, ThermoFisher Scientific #A31556). Fos was visualized by fluorescence microscopy with Olyvia software (Olympus Life Sciences). A blinded individual counted the Fos-positive neurons using Image J software À3.89 ** * Data are for mouse, except if denoted (r) rat or (h) human. ** The logPS is the blood-brain permeability-surface area product, calculated using http://bleoberis.bioc.cam.ac.uk/pkcsm/prediction. A logPS > À2 is considered penetrating, while logPS < À3 is non-penetrating . *** BAY60e6583 may be an antagonist at A 1 AR and A 3 AR and a partial agonist at A 2B AR. Superscripts indicate data source. SEMs are included for experimental results. a (Carlin et al., 2017) . b (Alnouri et al., 2015) . c (Jarvis et al., 1989) . d (Nikodijevic et al., 1990 ). e Current results. f (Gao et al., 2001 ). g (El-Tayeb et al., 2011) . h (Hide et al., 1992) . i (Kim et al., 1994) . j (Todde et al., 2000) . k (Duroux et al., 2017). (NIH). Display images were adjusted for brightness and contrast. Brain anatomy was defined using (Franklin and Paxinos, 2007) . Data are reported as mean ± SEM. Significance (two-tailed p < 0.05) was determined by t-test or ANOVA followed by post hoc Holm-Sidak multiple comparison tests.
Results
Adenosine causes hypothermia via mechanisms independent of A 1 AR and A 3 AR receptors
To determine if there are mechanisms in addition to A 1 AR and A 3 AR by which adenosine causes hypothermia, we studied Adora1 À/À ;Adora3 À/À mice, which lack both of these receptors.
Handling for dosing with vehicle increased Tb and activity. Treatment with a relatively modest adenosine dose (100 mg/kg, i. p (Eisner et al., 2017) .) produced robust hypothermia in Adora1 À/ À ;Adora3 À/À mice, approaching that seen in C57BL/6 J controls (Fig. 1) . Thus, adenosine can cause hypothermia independent of A 1 AR and A 3 AR.
Agonism at A 2A AR causes hypothermia
We used CGS-21680, a modestly selective A 2A AR agonist (Table 1) , to test if A 2A AR activation could produce hypothermia. CGS-21680 (0.01e1 mg/kg, i. p.) caused dose-dependent hypothermia and hypoactivity (Fig. 2AeC) . CGS-21680 is only~5-fold selective for A 2A AR over A 3 AR (Table 1 ); therefore, we tested its specificity using mice lacking A 2A AR. Treatment with CGS-21680 did not cause hypothermia in Adora2a À/À mice (Fig. 3AeC) . In contrast, CGS-21680 hypothermia was intact in Adora1 (Fig. 3DeF) . Adora2a is expressed in mast cells, but Kit WÀsh/ WÀsh mice, which lack mast cells, showed a hypothermic response to CGS-21680 (Fig. 3GeI) (Lateef et al., 2014 ) the observed increase in Tb (data not shown). Screening SCH442416 for off-target activities by the PDSP detected binding to the human 5HT 2B receptor (K i 0.91 mM), M 3 acetylcholine receptor (K i 6.8 mM), translocator protein (TSPO, K i 4.1 mM), and serotonin transporter (SERT, K i 6.1 mM). A lower dose of SCH442416 (0.6 mg/kg, i. p.) blocked the hypothermia caused by PSB-0777 (1 mg/kg i. p.) (Fig. 5AeE) . To distinguish a central vs peripheral site of action for A 2A AR antagonism, we tested MRS7352 (Duroux et al., 2017), a polar derivative of SCH442416 that is unlikely to reach brain parenchymal A 2A AR. Although less potent than SCH442416, MRS7352 retains selectivity for A 2A AR (Table 1) . MRS7352 (3 mg/kg, i. p.) completely blocked PSB-0777-induced hypothermia, without affecting physical activity (Fig. 5FeJ) . These data further support a peripheral site of action of A 2A AR agonists to cause hypothermia.
A 2A AR agonist-induced hypothermia is preceded by hypometabolism
A 2A AR agonist-induced hypothermia (CGS-21680, 0.25 mg/kg, i. p.) was accompanied by a marked reduction in metabolic rate, with the hypometabolism preceding the hypothermia (energy expenditure nadir at~26 min vs~65 min for Tb) (Fig. 6AeB) . The hypothermia and hypoactivity were accompanied by reduced food intake, which likely contributes to the lower respiratory exchange ratio, indicating relatively more fatty acid oxidation (Fig. 6CeE) .
Agonism at A 2B AR causes hypothermia
We next examined if A 2B AR agonism can also cause hypothermia. The non-nucleoside A 2B AR agonist BAY60-6583 (0.5e2 mg/kg, i. p.) caused dose-dependent hypothermia and hypoactivity (Fig. 7AeC ). BAY60-6583 shows modest adenosine receptor binding selectivity in mouse (Table 1) (Fig. 8AeC) . The lower dose (0.004 mg/kg, i.c.v.) caused hypothermia in C57BL/6 J (wild type, WT) but not Adora2b À/À mice (Fig. 8DeF) . These data suggest that the hypothermic effects of BAY60-6583 are via agonism at central (or central and peripheral) A 2B AR.
A 2B AR agonist-induced hypothermia is driven by hypometabolism
The effect of BAY60-6583 was studied using indirect calorimetry, where it lowered metabolic rate, respiratory exchange ratio, and food intake, in addition to Tb and physical activity (Fig. 9AeE) . The kinetics indicate that the reduction in metabolic rate is helping drive, not simply responding to the hypothermia. 
A 2B AR agonist induced hypothermia is accompanied by Fos induction in the preoptic area and the paraventricular hypothalamus
To identify candidate sites of BAY60-6583 action, we assessed neuronal activation after i.c.v. infusion (0.004 mg/kg, using Adora1 À/À ;Adora3 À/À mice to preclude any effects via A 1 AR or A 3 AR). BAY60-6583, but not vehicle, increased Fos immunostaining in the preoptic area (POA) and paraventricular hypothalamus (PVH) (Fig. 10) . Fos immunoreactivity was not significantly different in the ventromedial hypothalamus (VMH) or the dorsomedial hypothalamus (DMH), including subregions of the DMH (Wanner et al., 2017) . These results indicate that A 2B AR agonist causes neuronal activation in the PVH and POA, suggesting that these nuclei are involved in hypothermia.
Discussion
The results demonstrate that agonism of either peripheral A 2A AR or central A 2B AR causes hypothermia (Fig. S2) . Thus, agonism at any one of the four canonical adenosine receptors, A 1 AR, A 2A AR, A 2B AR, or A 3 AR can cause hypothermia. The clear evidence demonstrating four mechanisms notwithstanding, our experiments do not rule out additional mechanisms of adenosineinduced hypothermia, such as intracellular depletion of ATP causing AMPK activation (Eisner et al., 2017; Melvin and Andrews, 2009 ).
Mechanism of A 2A AR hypothermia
A 2A AR are widely expressed in the cardiovascular, immune, and nervous systems. Brain-penetrant A 2A AR antagonists acting on striatal neurons increase physical activity and are sometimes used clinically to treat Parkinson's disease (Dungo and Deeks, 2013; Kulisevsky and Poyurovsky, 2012) . However, our results suggest that brain A 2A ARs are not where A 2A AR agonists initiate hypothermia. Supporting data include the observations that two poorly brain penetrant agonists, CGS-21680 and PSB-0777, cause hypothermia, that infusion of CGS-21680 into the brain did not produce hypothermia, and that MRS7352, a presumably non-brain penetrant A 2A AR antagonist, inhibited the hypothermia. These data are consistent with the observation that the hypotensive effects of CGS-21680 in rats are mediated by peripheral A 2A ARs (Schindler et al., 2005) .
The hypoactivity caused by treatment with an A 2A AR agonist will reduce heat generation, but this probably makes a limited contribution to the reduced metabolic rate and hypothermia (Abreu-Vieira et al., 2015; Virtue et al., 2012) . A peripheral mechanism that could contribute to A 2A AR agonist-induced hypothermia is vasodilation, increasing heat loss. A 2A AR agonists cause vasodilation in cerebral, mesenteric, renal, and coronary arteries (Al Jaroudi and Iskandrian, 2009; Hansen et al., 2005; Kleppisch and Nelson, 1995; Phillis, 2004) , but the evidence for cutaneous vasodilation is modest (Fieger and Wong, 2010) . In addition, heat loss from isolated vasodilation should elicit compensatory hypermetabolism for heat generation (Warner et al., 2013) . In contrast, A 2A AR agonist-induced hypothermia is accompanied by the opposite, severe hypometabolism. Thus, while A 2A AR agonists cause vasodilation, they also trigger hypotension, hypoactivity, and hypometabolism. This coordinated response is likely a larger contributor to the hypothermia than heat loss from vasodilation.
The mouse CGS-21680 doses causing hypothermia (e.g., 0.25 mg/kg, i. p.) are typical of those used to study in vivo physiology. Thus, the possible contibution of hypothermia and hypometabolism to other observed phenotypes must be considered. For example, the hypoactivity caused by peripheral CGS-21680 (El Yacoubi et al., 2000; Ledent et al., 1997 ) is likely initiated peripherally, and not via agonism at brain A 2A AR.
A 2A AR are present in multiple immune system cell types, which could also contribute to driving the hypothermia. Our data rule out a role for mast cells. Further research is needed to define the cells (presumably in addition to vascular smooth muscle cells) on which A 2A AR agonists act to cause hypothermia and how the panoply of physiology needed to achieve hypothermia is choreographed.
Mechanism of A 2B AR hypothermia
A 2B AR has a lower affinity for adenosine and more divergent synthetic ligand selectivity compared to the other three adenosine receptors. A 2B AR are widely distributed, including in various hematopoietic cells, blood vessels, lung, astrocytes, and neurons (Fredholm et al., 2011; Goncalves et al., 2015; Lemos et al., 2015; Ohta and Sitkovsky, 2014) . Hypothermia was produced by BAY60-6583 with an i.c.v. dose only 1/150 th the amount of a similarly hypothermic i. p. dose. This suggests that A 2B ARs causing hypothermia are in the brain (or in both the brain and periphery). To identify where A 2B AR agonists might act in the brain, we mapped the neurons activated during BAY60-6583-induced hypothermia, with drug given i.c.v. to preclude effects from peripheral A 2B AR activation. A 2B AR is coupled to G s/q , so neurons are activated by BAY60-6583 action. The preoptic area of the hypothalamus (POA), a known thermoregulatory site (Morrison, 2016; Tan et al., 2016) , was activated, as was the paraventricular nucleus of the hypothalamus (PVH), which can inhibit thermogenesis (Madden and Morrison, 2009; Nakamura et al., 2017) . The experiment was underpowered to detect lower levels of activation in the other regions studied. While neuronal activation could occur with rewarming the body to reverse the hypothermia, the 1-h time point might minimize later contributions. Our data do not address whether the relevant A 2B ARs are on neurons or if the neuronal activation is indirect, due to agonist activation of astrocytes, vascular, immune system, or other cells (Sun and Huang, 2016) .
A 2A AR ligand selectivity
To identify adenosine receptor ligands as suitable tools for our in vivo mouse studies, we selected candidates based on rat or human affinity data and measured their binding affinity at mouse receptors. There can be profound species differences in adenosine or vehicle in C57BL/6 J (WT) and Kit WÀsh/WÀsh mice. Data are mean ± SEM, n ¼ 3e8/group; *p < 0.05, **p < 0.01, ***p < 0.001 vs vehicle within genotype. receptor ligand affinities (Alnouri et al., 2015) , and our results expand this literature. Examples of ligands binding more tightly to mouse A 1 AR than other species include: APEC, which is~100-fold better than for rat (Kim et al., 1994) , PSB-0777 which is > 500-fold better than for rat (El-Tayeb et al., 2011) , and regadenoson, which is > 1000-fold better than for human (Gao et al., 2001 ). Thus, both PSB-0777 and regadenoson, which are A 2A AR-selective in other species, are not selective in mouse, having both A 1 AR and A 2A AR activity. Some of these differences might be due to the molecular environment of the binding measurement. For example, a 57-fold difference in ligand affinity for human A 2A AR was observed, depending on which G-protein b subunit was present (Murphree et al., 2002) . These examples underscore the risks of extrapolating ligand binding affinities across species, even between rat and mouse. A drug's utility strongly depends on pharmacokinetics in addition to binding affinity. Adenosine is useful for coronary vasodilation since intravenous dosing gives the high exposure to vascular tissue and the very short half-life limits adverse effects from wider exposure (Al Jaroudi and Iskandrian, 2009 (Carlin et al., 2017) .
A 2B AR ligands
BAY60-6583 is the most commonly used A 2B AR agonist. It is a partial A 2B AR agonist with a modest affinity (K i at A 2B AR ¼ 136 nM). BAY60-6583 also binds A 1 AR and, less well, A 3 AR, and is an antagonist at these receptors (Alnouri et al., 2015) . Interestingly, in a cell-based assay BAY60-6583 had a 2.8 nM EC 50 at mouse A 2B AR, 50-fold better than the binding affinity (van der Hoeven et al., 2011) . Notably, the hypothermia induced by BAY60-6583 was due to A 2B AR, as it was completely abolished in the Adora2b À/À mouse.
Thus, BAY60-6583 is a valid tool to study induction of hypothermia in mice by A 2B AR.
Significance of A 2A AR-and A 2B AR-agonist induced hypothermia
Extracellular adenosine is a danger/injury signal, a general inducer of protective and anti-inflammatory mechanisms. Combined with previous data, our results demonstrate that agonism at any adenosine receptor, A 1 AR, A 2A AR, A 2B AR, or A 3 AR, can cause hypothermia. Thus, the body has redundant ways to sense adenosine and triggers multiple mechanisms to achieve a common response, hypothermia. Of the four receptors, A 1 AR is the best studied and most directly implicated in the regulation of Tb, possibly having direct actions on brain thermoregulatory centers (Shintani et al., 2005; Tupone et al., 2013) . The adenosine receptors probably do not have a major role in regulation of Tb in the nonchallenged state: knockout of any one of the four receptors does not affect baseline Tb, its diurnal rhythm, or the ability to enter fasting-induced torpor ( (Carlin et al., 2017; Carlin et al., 2016) and unpublished observations in Adora2a À/À and Adora2b À/À mice; but see (Yang et al., 2007 (Yang et al., , 2010 ). The multiplicity of mechanisms that can sense adenosine and evoke hypothermia likely reflects the importance and centrality of the protective/anti-inflammatory effects of hypothermia. 
